Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

Share Price is delayed by 15 minutes
Get Live Data
15.00    0.00 (0.00%)
Bid:
15.00
Ask:
16.90
Spread: 1.90 (12.667%)
Market Cap: £12.11m
LMS Live PriceLast checked at - London Stock Exchange

Intraday Lms Capital Share Chart

Holding(s) in Company

5 Sep 2016 14:05

LMS CAPITAL PLC - Holding(s) in Company

LMS CAPITAL PLC - Holding(s) in Company

PR Newswire

London, September 5

For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: iiLMS Capital PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rightsx
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iiiWithers Trust Corporation Limited, James McCarthy and Nick Kelsey (in their capacity as the Trustees of the Lord Rayne Will Trust)
4. Full name of shareholder(s) (if different from 3.):iv
THE BANK OF NEW YORK (NOMINEES) LIMITED
5. Date of the transaction and date on which the threshold is crossed or reached: v1.9.16
6. Date on which issuer notified:2.9.16
7. Threshold(s) that is/are crossed or reached: vi, viiIncrease from below 11% to above 11% but below 12%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODESituation previous to the triggering transactionResulting situation after the triggering transaction
Number of SharesNumber of Voting RightsNumber of sharesNumber of voting rights% of voting rights x
DirectDirect xiIndirect xiiDirectIndirect
Ord shares GB00B12MHD2811,247,38111,247,38111,247,38111.66
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrumentExpiration date xiiiExercise/ Conversion Period xivNumber of voting rights that may be acquired if the instrument is exercised/ converted.% of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrumentExercise priceExpiration date xviiExercise/ Conversion period xviiiNumber of voting rights instrument refers to% of voting rights xix, xx
NominalDelta
Total (A+B+C)
Number of voting rightsPercentage of voting rights
11,247,38111.66

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:Whilst there has been no acquisition or disposal of voting rights, as announced by the issuer on 1 September 2016, the overall number of shares in issue by total issued share capital has decreased from 103,584,592 Ordinary Shares to 96,441,735 Ordinary Shares, as a result of the completion of the Tender Offer. The effect of this reduction in the total issued share capital is to increase the proportion of voting rights held by the trustees of the Lord Rayne Will Trust from below to above the 11% threshold, which has prompted this notification. The voting rights are held by The Bank of New York (Nominees) Limited, which is the sub-custodian of Multrees Investor Services Limited, which holds the shares under an investment management agreement with Stonehage Fleming Investment Management Limited, for the trustees of the Lord Rayne Will Trust.
14. Contact name:Robert McLean
15. Contact telephone number:020 7597 6000
Date   Source Headline
13th May 20263:32 pmRNSResults of 2026 Annual General Meeting
24th Apr 20263:37 pmRNSTR‑1: Notification of Major Holdings
24th Apr 20267:00 amRNSFirst Quarter 2026 Update
17th Apr 20261:09 pmRNSNotice of Annual General Meeting
19th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
17th Feb 202612:37 pmRNSTR‑1: Notification of Major Holdings
16th Feb 20267:00 amRNSCompany Update and Unaudited Net Asset Value
13th Jan 20267:00 amRNSSecond Return of Capital
4th Nov 20257:00 amRNS3rd Quarter Trading Update
8th Oct 20259:30 amRNSChange of Auditor
11th Aug 20257:01 amRNSHalf-year Report
11th Aug 20257:00 amRNSInvestment in Dacian
15th Jul 20253:21 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSStatement re B Share issue
15th May 202510:23 amRNSResult of AGM & GM
14th May 20253:01 pmRNSResult of AGM & GM
14th May 20257:00 amRNSAGM Statement
24th Apr 202510:43 amRNSNotice of GM Broadcast
24th Apr 202510:36 amRNSNotice of GM
22nd Apr 20257:00 amRNS1st Quarter Results
8th Apr 20251:47 pmRNSNotice of AGM Broadcast
8th Apr 20251:34 pmRNSNotice of AGM
28th Mar 20257:00 amRNSFinal Results
17th Mar 20259:07 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSStatement re proposed managed realisation
25th Feb 20251:27 pmRNSHolding(s) in Company
19th Feb 20258:44 amRNSHolding(s) in Company
13th Feb 20257:00 amRNSNet Asset Value(s)
20th Dec 20249:22 amRNSDirector/PDMR Shareholding
13th Nov 20244:32 pmRNSCompany Secretary Change
18th Oct 20247:00 amRNSThird Quarter 2024 Update
5th Sep 20243:49 pmRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSSenior Independent Director Appointment
31st Jul 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSUpdate on Investment
16th May 20244:54 pmRNSResult of AGM and Dividend Declaration
15th May 20247:00 amRNSDirectorate Change
8th May 20249:19 amRNS1st Quarter Results
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.